Seger för stamcellsforskning

Får fortsatt statlig finansiering i USA.

Kina lärs upp av FDA

Den kinesiska läkemedelsmyndigheten vill lära sig om det regulatoriska arbetet i USA.

Medivirs samarbetsstudie inledd

Första patienten i samarbetsstudien, där Medivirs preparat kombineras med läkemedel från MSD, har påbörjat dosering,

Oasmia gets a confirmation

FDA has granted Oasmia an expedited review status for Paclical Vet.

"Det ligger i allas intresse att samarbeta"

Virononas vd Mohammed Homman kommenterar SwedenBios förslag om att inrätta program för explorativ samverkansforskning inom life science.

Major changes to the Q-Med board

The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.

How to get the most out of the fair

Ny finansdirektör hos Elekta

Efter flera ledande finansiella roller i bolaget blir Gustaf Salford nu ekonomi- och finansdirektör hos Elekta.

Respiratorius hunts millions

The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.

Dry blood DNA storage on a matrix

Qiagen recently presented a method of dry blood sample storage as an alternative to storage in freezers.

New CEO to Promedvi

Sigrun Axelsson has taken on the leadership of the Lund-based medtech company.

This is Sweden's largest life science region

About 60 percent of all jobs within swedish life science are found in the Stockholm-Uppsala area. This was stated in a report presented at Scanlab & Biotech Forum today.

Höjer bud på Actelion

Johnson & Johnson diskuterar förvärv av det schweiziska läkemedelsbolaget, och uppges nu ha höjt sitt bud.

Medicult acquires embryo scanner

The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.

New nanotech professor to DTU

The Danish University of Technology, DTU, has appointed Kristoffer Almdal as professor to DTU Nanotech.

Biotage is regrouping

The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.

They’re all doing it – buying drug research

It is not easy to navigate the complex infrastructure for drug development in Sweden, where various contract players exist alongside the pharmaceutical companies.

Vill sälja USA-verksamheten

Enligt rykten diskuterar Meda en försäljning av sin amerikanska verksamhet.

Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.

Astrazenecas patent ogiltigförklaras

Läkemedelsföretagets patent för inhalationsbehandlingen Pulmicort bedöms som ogiltigt i USA.

Nya strategier för att utrota malaria

Ny studie visar hur Zanzibar gjort för att lyckas i kampen mot sjukdomen.

Collaboration brings next generation drugs

Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.

Vitrolife wants to acquire Medicult

The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.

Ger råd till Glactone

Fyra experter tar plats i Glactones nya vetenskapliga råd.